TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CDXS

Codexis Inc

Healthcare · Biotechnology

1.40$ +1.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow CDXS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.9% -1.0% -5.5% -17.5% -23.3% -18.3% -23.8% -13.6% 8.1% -75.0% -83.3% -27.5%
18.9% 12.9% 9.3% 2.1% 1.9% 6.7% 6.6% 5.7% 7.4% 14.1% 8.3% 7.5%
13.1% 12.3% 11.6% 14.2% 13.0% 10.1% 11.2% 11.1% 10.5% 14.2% 22.1% 13.7%
16.5% 12.3% 11.5% 13.8% 13.2% 10.9% 11.3% 8.3% 9.4%
17.5% -7.4% -8.8% 12.6% -20.4% -18.5% -5.6% -7.3% 15.6% -26.0% -20.2% 9.1%
0.9% 2.9% 1.8% 2.0% 4.6% 5.4% 5.4% 13.2% 6.0% 6.3% 7.3% 6.4%
13.2% -3.0% -1.7% -1.8% -4.6% -5.4% -8.3% -20.4% -9.8% -6.9% -96.0% 33.4%
0.0% 0.0% 0.0% 0.0% 4.2% 1.8%
-2.3% -4.3% -3.1% -3.3% -5.3% -4.2% -1.8% -1.2% -1.1% -0.6%
-0.5% -0.4% -0.4% -0.3% -0.4% -0.4% -0.1% 0.0% 0.0% 0.0% 49.7% 14.1%
-1.7% -3.6% -1.0% 43.3% 63.7% 78.8% 117.0% 3.6% -0.4% 11.6% 102.0% 39.7%
12.3% -7.7% -8.3% 23.9% 35.8% 55.1% 84.9% -30.5% -2.1% -70.3% -77.3% 45.5%
0.1% -3.9% -7.3% -19.5% -27.8% -23.8% -29.3% -26.8% 2.1% -81.3% -90.5% -33.9%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?